» Articles » PMID: 37462534

Synthesis of P-Modified DNA from Boranophosphate DNA As a Precursor Via Acyl Phosphite Intermediates

Overview
Journal J Org Chem
Specialty Chemistry
Date 2023 Jul 18
PMID 37462534
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we successfully synthesized several kinds of -modified nucleic acids from boranophosphate DNAs via an acyl phosphite intermediate in solution and on a solid support. In the solution-phase synthesis, phosphorothioate diester, phosphotriester, and phosphoramidate diester were synthesized in a one-pot reaction from boranophosphodiester via the conversion of an acyl phosphite as a key intermediate. In addition, doubly -modified nucleic acid derivatives which were difficult to synthesize by the phosphoramidite and -phosphonate methods were also obtained by the conversion reaction. In the solid-phase synthesis, a boranophosphate derivative was synthesized on a solid support using the -boranophosphonate method. Then, an acyl phosphite intermediate was formed by treatment with pivaloyl chloride in pyridine, followed by appropriate transformations to obtain the -modified derivatives such as phosphotriester and phosphorothioate diester. Notably, it was suggested that the conversion reaction of a boranophosphate to a phosphorothioate diester proceeded with retention of the stereochemistry of the phosphorous center. In addition, a phosphorothioate/phosphate chimeric dodecamer was successfully synthesized from a boranophosphate/phosphate chimeric dodecamer using the same strategy. Therefore, boranophosphate derivatives are versatile precursors for the synthesis of -modified DNA, including chimeric derivatives.

Citing Articles

A Visual Compendium of Principal Modifications within the Nucleic Acid Sugar Phosphate Backbone.

Novikova D, Sagaidak A, Vorona S, Tribulovich V Molecules. 2024; 29(13).

PMID: 38998973 PMC: 11243533. DOI: 10.3390/molecules29133025.


Self-Penetrating Oligonucleotide Derivatives: Features of Self-Assembly and Interactions with Serum and Intracellular Proteins.

Bauer I, Ilina E, Zharkov T, Grigorieva E, Chinak O, Kupryushkin M Pharmaceutics. 2023; 15(12).

PMID: 38140119 PMC: 10747088. DOI: 10.3390/pharmaceutics15122779.

References
1.
Straarup E, Fisker N, Hedtjarn M, Lindholm M, Rosenbohm C, Aarup V . Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates. Nucleic Acids Res. 2010; 38(20):7100-11. PMC: 2978335. DOI: 10.1093/nar/gkq457. View

2.
Anderson B, Freestone G, Low A, De-Hoyos C, Iii W, Ostergaard M . Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides. Nucleic Acids Res. 2021; 49(16):9026-9041. PMC: 8450106. DOI: 10.1093/nar/gkab718. View

3.
Kawanaka T, Shimizu M, Shintani N, Wada T . Solid-phase synthesis of backbone-modified DNA analogs by the boranophosphotriester method using new protecting groups for nucleobases. Bioorg Med Chem Lett. 2008; 18(13):3783-6. DOI: 10.1016/j.bmcl.2008.05.053. View

4.
Uehara S, Hiura S, Higashida R, Oka N, Wada T . Solid-phase synthesis of P-boronated oligonucleotides by the H-boranophosphonate method. J Org Chem. 2014; 79(8):3465-72. DOI: 10.1021/jo500185b. View

5.
Hall A, Wan J, Shaughnessy E, Ramsay Shaw B, Alexander K . RNA interference using boranophosphate siRNAs: structure-activity relationships. Nucleic Acids Res. 2004; 32(20):5991-6000. PMC: 534620. DOI: 10.1093/nar/gkh936. View